Wednesday, September 16, 2026Latest filing Sep 14, 2026

Bernie Moreno Periodic Transaction Report

Filed May 22, 2026 · Senate eFD · 1 transaction

U.S. Senator · R · OH · All trades by Bernie Moreno

On May 22, 2026, Sen. Bernie Moreno (R-OH) filed a periodic transaction report with the Senate eFD disclosing 1 transaction (1 sale) dated May 6, 2026.

The filing covers 1 ticker, including $ETOR.

Reported amount ranges sum to $100K–$250K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 16 days.

Source document: Senate eFD filing 86810b3e-3dee-4e8e-9b47-6d3822385b7d

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Bernie Moreno · Sold $ETOR · May 6 · $100K–$250K

0.51MED
Disclosure speedx 0.250.60
Trade sizex 0.250.75
Cluster activityx 0.150.00
Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Bernie Moreno

Get an email the moment Bernie Moreno files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
16d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
May 6, 2026ETOReToro Group Ltd. - Class A Common SharessellSelf$100K–$250K16d

Other recent filings by Bernie Moreno

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →